According to a Dec. 18 news release, the device is known for its potential to reduce retear rates in rotator cuff repair cases and enhance long-term patient outcomes. The implant is a fully resorbable, synthetic-nanofiber scaffold designed to optimize healing at the tendon-bone interface in rotator cuff repairs.
The Rotium “supports the body’s natural healing processes,” according to the news release, and can boost tissue integration.
At the Becker’s 32nd Annual Meeting: The Business and Operations of ASCs, taking place October 29-31 in Chicago, ASC leaders, surgeons and healthcare executives will explore strategies to drive growth, enhance operational performance, navigate reimbursement challenges and prepare for the future of ambulatory surgery. Apply for complimentary registration now.
